INTRODUCTION
Mammalian genomes, despite lack of chitin (poly N glucosamine) synthesis in mammalia, code a set of homologous chitinase like proteins. On the basis of amino acid sequences and protein structure relation ships they have been grouped in glycosyl hydrolase family 18, which also includes bacterial and plant chitinases [1] . In human there are six proteins of this family [2] , and two of them, macrophage chitotriosi dase 1 (chitinase 1, CHIT1) [3] and acidic mamma lian chitinase (AMCase) [4] , are catalytically active chitinases. Other chi lectins are chitinase 3 like 1 (CHI3L1) or human cartilage glycoprotein 39 (HC gp 39) or YKL 40 [5] , chitinase 3 like 2 (CHI3L2) or YKL 39 [6] , oviductin (oviductal glycoprotein, ovi duct specific glycoprotein precursor, estrogen depen dent oviduct protein, mucin 9, OVGP1) [7] and less homologous chitinase like protein, which interacts with endocytic/sorting receptor stabilin 1 (stabilin 1 interacting chitinase like protein, SI CLP) [8] .
YKL 40 is the most investigated protein in chiti nase like signal lectin family. It has molecular weight 1 The article is published in the original. of about 40 kDa and N glycosylation at Asn60 (2 β(1,4) N acetyl d glycosamine, NAG). YKL 40 monomer consists of 383 amino acids, contains signal peptide Met1 Ala21 for secretion and two structure domains [9] . N terminal amino acids of its mature form are tyrosine (Y), lysine (K), leucine (L) [5] . This lectin acts as a proliferative [10] , anti apoptotic [11, 12] , migration and adhesion [13] factor, it enhances bacterial adhesion to colonic epithelial cells through the interaction with bacterial chitin binding protein [14] . CHI3L1 gene is expressed in synovial cells, artic ular cartilage chondrocytes, and liver. It is overex pressed in macrophages during the last stages of differ entiation; its expression is increasing significantly under pathological conditions such as inflammation or different tumors notably squamous cell carcinoma of the head and neck, multiple myeloma, acute mye loid leukemia, small cell lung cancer, primary breast cancer, ovarian cancer stage III, colorectal carcinoma, and glioblastoma [15] . CHI3L1 is overexpressed in glioblastomas in comparison with low grade gliomas and normal brain [16] and a correlation between high expression of CHI3L1 and short survival of patients was observed [17] . It was reported that YKL 40 pro motes the growth of human synovial cells as well as ) . YKL 39 was identified as a pro tein in conditioned medium from human articular cartilage chondrocytes primary culture that co puri fied with YKL 40. Its amount is approximately 4% of total proteins in chondrocyte conditioned medium while content of YKL 40 is 33%. The highest level of YKL 39 mRNA was detected in chondrocytes, also in synoviocytes, lung, and heart [6] . No YKL 39 mRNA was detected in brain, spleen, kidney, pancreas, or liver. YKL 39 gene, but not YKL 40, is upregulated in chondrocytes of patients with osteoarthritis [18] . Pre viously using Serial Analysis of Gene Expression (SAGE), Northern blotting and PCR analysis we have shown the increasing YKL 39 gene expression in glio blastomas. However, Western blot analysis did not show simultaneous production of YKL 39 and YKL 40 [19] in spite of high degree of their sequence identity.
The work described here is going to demonstrate that YKL 39 also activates extracellular signal regu lated kinase (ERK) mediated signaling cascade, which is associated with the control of proliferation or differentiation, in both, human embryonic kidney (HEK293) and human glioblastoma (U87 MG) cells.
MATERIAL AND METHODS
Mouse monoclonal antibody specific for the phos phorylated forms of ERK1/ERK2 as well as rabbit pan specific polyclonal antibody to this kinases were obtained from "Santa Cruz Biotechnology" (USA), and horseradish peroxidase anti mouse and anti rab bit Ig conjugates were obtained from "Promega" (USA). Enhanced chemiluminescence reagents for visualization of bound Igs on Western blots were from "Amersham Pharmacia Biotechnology" (Austria).
After restriction of pGemT Easy CHI3L2 [19] , the Nde I/Xho I fragment was subcloned in expression vector pET 24a (+) from "Novagen" (Germany). The nucleotide sequence was checked by the dideoxy method ("3130 Genetic Analyzer, Applied Biosys tems", USA). E. coli (BL21) cells transformed by recombinant plasmid pET 24a (+) CHI3L2 were grown, and synthesis of recombinant protein was induced by IPTG. Affinity purification of YKL 39, containing His6 at the C terminus, was carried out on Ni NTA agarose (Ni 2+ charged nitriloacetic acid modified agarose) under denaturing conditions in the presence of 8 M urea according to manufacturer's protocol of "Qiagen" (USA). Protein products were analyzed by 12% SDS PAGE and Coomassie Brilliant Blue R250 staining. Protein content was determined using the Bradford assay [20] . Purified YKL 39 was stored frozen at minus 20°C in aliquots to avoid repeated freeze thawing and protein denaturation.
HEK 293 and U 87 MG cells were obtained from the Bank of cell lines from human and animal tissue (R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, Kyiv, Ukraine). Frozen stocks of cell lines were expanded through two or three passages before use. All cells were grown in Dulbecco's Modification of Eagles Medium (DMEM) supple mented with 10% FBS and 100 μg/ml penicillin/100 units/ml streptomycin in an environment of 95% air/5% CO 2 . For investigation of ERK1/ERK2 phosphorylation cells were seeded into 6 well tissue cul ture plates in DMEM containing 10% FBS.
To perform RT PCR, total RNA was isolated from HEK 293 and U 87 MG cells using the Tri Reagent from SIGMA. 5 μg of RNA was reverse transcribed by oligo(dT) priming (M MuLV RT, "Fermentas", Lithuania). Relative transcript levels of CHI3L1 and CHI3L2 in two cDNA samples and control β actin (ACTS) cDNA were then determined by PCR using the following primers pairs: CHI3L1 forward 5' ACA CACTCAAGAACAGGAA 3', reverse 5' TGATT AGGGTGGTAAAATGC 3'; CHI3L2 forward 5' TCAAAACCAAGAATCCCAAAC 3', reverse 5' ATCAGCACAGTGAAATGAGT 3'; ACTB for ward 5' AACTACCTTCAACTCCATCA 3', reverse 5' GTCATACTCCTGCTTGCT 3'. As a positive control for each primer pair were used plasmid vectors containing CHI3L1 cDNA (pcDNA4 A) and CHI3L2 cDNA (pET 24a (+). The following thermal cycling parameters were used: 95°C for 2 min, 35 cycles of 95°C for 40 s, 59°C for 30 s, and 72°C for 30 s. PCR products were resolved on 1.5% agarose gel containing ethidium bromide. The expected sizes of PCR prod ucts were 222, 213 and 261 bp for CHI3L1, YKL 39 and ACTB, respectively.
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Same as CHI3L1, SAGE included CHI3L2 to the list of 44 genes with more than 5 fold increased expression in glioblastoma as compared to normal brain [21] . However, the quantity of YKL 39 protein is much less in glioblastomas than those for YKL 40 [19] .
In contrast to chitinase like glycoprotein CHI3L1, which has been characterized extensively with respect to its expression patterns and possible association with degenerative diseases [15] , the features of its closest homologue YKL 39 were poorly described. The fact that one mammalian member of glycohydrolase fam ily 18 has mitogenic activity [10] and the identification of a family of growth factors in the fruit fly D. melano gaster, as chitinase like proteins [22] , indicates that this function may be conserved across a wide range of species. A dose dependent growth stimulation was observed when fibroblast cell lines were exposed to YKL 40 [10, 11] , showing that mitogen activated protein kinase signaling pathway is involved in mediat ing the mitogenic response and that phosphorylation of ERK1/ ERK2 occurred in a dose dependent fash ion upon addition of YKL 40. High homology of nucleotide and amino acid sequences of YKL 39 and YKL 40 (Fig. 1) suppose some identity of their func tions.
To test this possibility, we made an attempt to find if YKL 39 also induces phosphorylation of ERK1/ERK2. For the beginning we used HEK293 cell line which same as many other cell types, in monolayer culture can not be maintained in unsupple mented culture medium more than one week without loss of viability. The requirement for addition of sup plementation is common for cell lines which do not produce endogenously any growth factor. Cells were grown to near confluence and serum starved for 48 hrs followed by exposure to purified YKL 39 at concentrations ranging from 0 to 100 ng/ml or BSA (100 ng/ml) in unsupplemented culture medium. Cells were lysed after 60 min of exposure and cell lysates were analysed by Western blotting with either phosphorylation specific (P MAPK) or phosphoryla tion independent (Total MAPK) antiserum against the MAP kinases ERK1 and ERK2. The results illus trated in Fig. 2a , suggest that ERK1/ERK2 phospho rylation was stimulated in these cells following addi tion of YKL 39. The lowest effective concentration of YKL 39 was in 5 fold larger that eliciting a mitogenic response to YKL 40 [10] . No ERK1/ ERK2 phospho rylation was observed in cells exposed to medium without YKL 39 addition or in cells exposed to medium supplemented with BSA.
To investigate if YKL 39 may phosphorylate cells derived from glial tumor, we repeated the described above experiment but this time with human glioblas toma U 87 MG cell line. ERK1/ERK2 phosphoryla tion was also stimulated in these cells (Fig. 2b) . How ever, in contrast to HEK293 cells, ERK1/ERK2 phos phorylation was observed in U 87 MG cells exposed to medium without YKL 39 addition or in cells exposed to medium supplemented with BSA suggesting that some YKL 39 or other growth factor is produced in U 87 MG cells. Indeed, PCR on total U 87 MG cDNA with specific primers to CHI3L1, CHI3L2 and ACTB revealed presence of all three RNAs in these cells (Fig. 3a) and only positive control β actin RNA in HEK293 cells (Fig. 3b) .
As it was shown in many publications, ERK1 and ERK2 regulate proliferation and differentiation and form part of a MAPK module that includes Raf MAP KKKs and the MEK1/MEK2 MAPKK. They are activated by mitogenic stimuli such as growth factors, cytokines and phorbol esters, which activate a variety of cell surface receptor tyrosine kinases or G pro tein coupled receptors. This leads to activation of Ras by associated SOS (son of sevenless). Ras GTP then triggers activation of Raf isoforms (A Raf, B Raf, C Raf/Raf 1) and recruitment of Raf to the plasma membrane, followed by phosphorylation of MEK1/MEK2 and then ERK1, ERK2. This is facili tated by the scaffold protein KSR, which links the three tiers of kinases to Ras. Other scaffold proteins can also tether the ERK module. ERK1/ERK2 have many known targets, including key transcription fac tors, such as AP 1, NF kB, Myc, kinases, such as Rsk, the cell survival regulator Bcl 2, cPL2 and the cytoskeletal scaffold paxillin. Depending on the strength and duration of stimulation, activation of the Fig. 2 . YKL 39 induces a dose dependent phosphorylation of ERK1/ERK2 in (a) human embryonic kidney 293 (HEK293) and (b) human glioblastoma (U 87 MG) cells. Cells were grown to near confluence and serum starved for 24 hrs followed by expo sure to purified YKL 39 at concentrations ranging from 0 to 100 ng/ml or BSA (150 ng/ml) in unsupplemented culture medium. Cells were lysed after 60 min of exposure and cell lysates were analysed by Western blotting with phosphorylation specific (P MAPK) antibody and following visualization they were stripped and re probed with a pan specific (Total MAPK) antibody to determine total ERK1/2 protein. ERK1/ERK2 MAPKs can lead to either proliferation or differentiation (for review see [23] ). Thus, the results presented here demonstrate that YKL 39 may initiate the phosphorylation of ERK1/ERK2 leading to the initiation of MAP kinase signaling cascade in human embryonic kidney (HEK293) and human glioblastoma (U87 MG) cells. The finding is consistent with the well established role of this signaling pathway in the propagation of mitoge nic signals [24] . The activation of cytoplasmic signal transduction pathway suggests that YKL 40 and YKL 39 interact with one or several signaling compo nents on the plasma membrane.
The inhibition of the mitogenic response of the cells to YKL 40 by either the MAP kinase or PI 3K inhibitors suggested that both pathways are required for the cells to complete progression through the mitotic cycle and only one of these pathways is insuf ficient for the cells to complete mitosis [10] . Recent data suggest that PI 3K activation is required for the progression of mitosis, promoting the entry of quies cent cells into the S phase [25] , and the downstream phosphorylation of AKT is in part responsible for the propagation of this signal. The possible participation YKL 39 also in activation of PI 3K signaling passway is currently under investigation.
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